Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Gains from Investment Securities (2016 - 2026)

Aytu Biopharma has reported Gains from Investment Securities over the past 11 years, most recently at $1382.0 for Q4 2025.

  • Quarterly Gains from Investment Securities changed N/A to $1382.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1382.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $211618.0 for FY2025, 44.41% up from the prior year.
  • Gains from Investment Securities was $1382.0 for Q4 2025 at Aytu Biopharma, down from $140000.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $446000.0 in Q3 2024 and troughed at -$1.3 million in Q1 2022.
  • The 5-year median for Gains from Investment Securities is $52784.0 (2023), against an average of -$76611.9.
  • Year-over-year, Gains from Investment Securities tumbled 103000.0% in 2023 and then surged 486.84% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $277000.0 in 2021, then crashed by 72.92% to $75000.0 in 2022, then rose by 1.33% to $76000.0 in 2023, then surged by 486.84% to $446000.0 in 2024, then plummeted by 99.69% to $1382.0 in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Gains from Investment Securities are $1382.0 (Q4 2025), $140000.0 (Q3 2025), and $219244.0 (Q1 2025).